Chronic Obstructive Pulmonary Disease (COPD) | Norton Healthcare

Indication: Chronic Obstructive Pulmonary Disease (COPD)

A Sham Controlled Prospective Randomized Clinical Trial of the RejuvenAir® System for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease with Chronic Bronchitis (SPRAY-CB)

Chronic Bronchitis

Device Study

Principal Investigator: Tanya Wiese, DO
Norton Heart &; Vascular Institute

Sponsor: CSA Medical, Inc

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.